1
Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
| Species | Human |
| Cat.No | ABC-X0045C |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
| Product Category | Transfected Stable Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Lymphocyte |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 °C, 5% CO₂ |
| Source Organ | Lymphatic |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Overexpression Stable Cell Lines |
| Host Cell | BAF3 |
Human ERBB2 (T798I_Q799E) BAF3 Cell Line is a genetically engineered model derived from selected murine Ba/F3 parental cell line based on customers’ requirement. ERBB2 (T798I_Q799E) BAF3 mutant cell line is generated by stable integration of exogenous human ERBB2 gene containing dual mutations (T798I and Q799E) into Ba/F3 host cells using our optimized lentiviral transduction system.
Target
ERBB2 (HER2) is a transmembrane receptor tyrosine kinase driving oncogenic signaling through PI3K/AKT and MAPK pathways. The T798I mutation is a known gatekeeper alteration associated with resistance to tyrosine kinase inhibitors, while Q799E further enhances constitutive kinase activity. The combination of these mutations allows in-depth analysis of drug resistance mechanisms in HER2-positive cancers. AcceGen offers stable models for functional and pharmacological studies of complex mutations. Polyclonal or monoclonal is optional based on customers’ research needs.
For research use only